Nykode Therapeutics Competitors and Similar CompaniesClear all
Nykode Therapeutics's competitors and similar companies include Gradalis, Takeda, Biocon and Shanghai Junshi Biosciences.
 Nykode Therapeutics Nykode Therapeutics (formerly known as Vaccibody) is a biopharmaceutical company dedicated to the discovery and development of immunotherapies. |  Gradalis Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. | ||
Founding Date | Founding Date 2007 | Founding Date 2003 | Founding Date 1781 | Founding Date 1978 | Founding Date 2012 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Oslo, NO HQ | Locations Carrollton, US HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Shanghai, CN HQ | |
Employees | Employees 135 | Employees 25 | Employees 47,4554% decrease | Employees 16,315 | Employees 2,578 |
Valuation ($) | Valuation ($) 144.4 m | Valuation ($) N/A | Valuation ($) 43.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.2m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) ₹150.5b (FY, 2025) | Revenue (est.) ¥1.9b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods ₹52b (FY, 2025) | Cost of goods ¥410.7m (FY, 2024) |
Gross profit | Gross profit $9.2m (FY, 2024) | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit ₹112.7b (FY, 2025) | Gross profit ¥1.5b (FY, 2024) |
Net income | Net income ($38.8m) (FY, 2024) | Net income N/A | Net income ¥108.1b (FY, 2025) | Net income ₹14.3b (FY, 2025) | Net income (¥1.4b) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 31.5m | Total funding raised $ 67.9m | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Gradalis
HQ
Carrollton, US
Employees
25
Gradalis is a biotechnology company focused on the development and commercialization of personalized therapeutics to treat cancer.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyShanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View company